NCT06760936View on ClinicalTrials.gov

Pixantrone as Bridging Therapy to Allogenic Transplant or CAR-T Cell Therapy in DLBCL Patients

Active, not recruitingOBSERVATIONAL

Enrollment

15

Participants

Timeline

Start Date

June 6, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions

Diffuse Large B Cell Lymphoma (DLBCL)

Trial Locations (1)

40138

IRCCS Azienda Ospedaliero - Universitaria di Bologna, Bologna

All Listed Sponsors

lead

IRCCS Azienda Ospedaliero-Universitaria di Bologna

OTHER